Lesley Fallowfield is an expert in Oncology at University of Sussex (United Kingdom). As of October 2026, ScienceLeadR ranks Lesley Fallowfield in the top 1% of experts worldwide for Breast Neoplasms and Breast Diseases. Lesley Fallowfield has authored 474 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 1,808 (community average: 125). How the SLR is computed.

LeadR Profile

Lesley Fallowfield University of Sussex United Kingdom
1 808 ScienceLeadR Reputation 1808
Network Map

Oncology

Subspecialties: Thoracic And Cardiovascular Surgery - Gynecology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026

Source: PubMed

University of Sussex

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 474

Citations

Citations: 44 495 1st author: 93 Last author: 92 Unique author: 71


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Communication barriers for d/Deaf people with cancer: a scoping review.
PMID 42717155 — communication, neoplasms, communication barriers, palliative care
Support Care Cancer20261
Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication.
PMID 42169666 — breast neoplasms, pharmaceutical preparations, communication, neoplasms, perception, breast, therapeutics, diarrhea
Future Oncol20260
Evaluation of a novel communication workshop for healthcare professionals working with metastatic breast cancer patients.
PMID 42127481 — breast neoplasms, communication, neoplasms, breast, work, burnout, psychological
Breast20260
Biomarker recall and understanding among people living with metastatic breast cancer - results from an international patient survey.
PMID 41719679 — mental recall, breast neoplasms, neoplasms, multiple chronic conditions, biomarkers, breast, diagnosis, therapeutics
Breast20260
Improving communication between healthcare professionals and patients living with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 5).
PMID 41298013 — breast neoplasms, communication, neoplasms, breast, therapeutics, breast diseases
Breast20250

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 3 3
Phase 2 2
Phase 4 1

By status:

Completed 8
Active not recruiting 1

By type:

Interventional 9

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 1
multicentricup10 6

Main Topics

LeadR Networks

Main global connection map